Cargando…

Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5

Hermansky-Pudlak syndrome (HPS) is a heterogeneous group of genetic disorders typically manifesting with tyrosinase-positive oculocutaneous albinism, bleeding diathesis, and pulmonary fibrosis, in some subtypes. Most HPS subtypes are associated with defects in Biogenesis of Lysosome-related Organell...

Descripción completa

Detalles Bibliográficos
Autores principales: Stephen, Joshi, Yokoyama, Tadafumi, Tolman, Nathanial J., O’Brien, Kevin J., Nicoli, Elena-Raluca, Brooks, Brian P., Huryn, Laryssa, Titus, Steven A., Adams, David R., Chen, Dong, Gahl, William A., Gochuico, Bernadette R., Malicdan, May Christine V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351877/
https://www.ncbi.nlm.nih.gov/pubmed/28296950
http://dx.doi.org/10.1371/journal.pone.0173682
_version_ 1782514843261075456
author Stephen, Joshi
Yokoyama, Tadafumi
Tolman, Nathanial J.
O’Brien, Kevin J.
Nicoli, Elena-Raluca
Brooks, Brian P.
Huryn, Laryssa
Titus, Steven A.
Adams, David R.
Chen, Dong
Gahl, William A.
Gochuico, Bernadette R.
Malicdan, May Christine V.
author_facet Stephen, Joshi
Yokoyama, Tadafumi
Tolman, Nathanial J.
O’Brien, Kevin J.
Nicoli, Elena-Raluca
Brooks, Brian P.
Huryn, Laryssa
Titus, Steven A.
Adams, David R.
Chen, Dong
Gahl, William A.
Gochuico, Bernadette R.
Malicdan, May Christine V.
author_sort Stephen, Joshi
collection PubMed
description Hermansky-Pudlak syndrome (HPS) is a heterogeneous group of genetic disorders typically manifesting with tyrosinase-positive oculocutaneous albinism, bleeding diathesis, and pulmonary fibrosis, in some subtypes. Most HPS subtypes are associated with defects in Biogenesis of Lysosome-related Organelle Complexes (BLOCs), which are groups of proteins that function together in the formation and/or trafficking of lysosomal-related endosomal compartments. BLOC-2, for example, consists of the proteins HPS3, HPS5, and HPS6. Here we present an HPS patient with defective BLOC-2 due to a novel intronic mutation in HPS5 that activates a cryptic acceptor splice site. This mutation leads to the insertion of nine nucleotides in-frame and results in a reduced amount of HPS5 at the transcript and protein level. In studies using skin fibroblasts derived from the proband and two other individuals with HPS-5, we found a perinuclear distribution of acidified organelles in patient cells compared to controls. Our results suggest the role of HPS5 in the endo-lysosomal dynamics of skin fibroblasts.
format Online
Article
Text
id pubmed-5351877
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-53518772017-04-06 Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5 Stephen, Joshi Yokoyama, Tadafumi Tolman, Nathanial J. O’Brien, Kevin J. Nicoli, Elena-Raluca Brooks, Brian P. Huryn, Laryssa Titus, Steven A. Adams, David R. Chen, Dong Gahl, William A. Gochuico, Bernadette R. Malicdan, May Christine V. PLoS One Research Article Hermansky-Pudlak syndrome (HPS) is a heterogeneous group of genetic disorders typically manifesting with tyrosinase-positive oculocutaneous albinism, bleeding diathesis, and pulmonary fibrosis, in some subtypes. Most HPS subtypes are associated with defects in Biogenesis of Lysosome-related Organelle Complexes (BLOCs), which are groups of proteins that function together in the formation and/or trafficking of lysosomal-related endosomal compartments. BLOC-2, for example, consists of the proteins HPS3, HPS5, and HPS6. Here we present an HPS patient with defective BLOC-2 due to a novel intronic mutation in HPS5 that activates a cryptic acceptor splice site. This mutation leads to the insertion of nine nucleotides in-frame and results in a reduced amount of HPS5 at the transcript and protein level. In studies using skin fibroblasts derived from the proband and two other individuals with HPS-5, we found a perinuclear distribution of acidified organelles in patient cells compared to controls. Our results suggest the role of HPS5 in the endo-lysosomal dynamics of skin fibroblasts. Public Library of Science 2017-03-15 /pmc/articles/PMC5351877/ /pubmed/28296950 http://dx.doi.org/10.1371/journal.pone.0173682 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Stephen, Joshi
Yokoyama, Tadafumi
Tolman, Nathanial J.
O’Brien, Kevin J.
Nicoli, Elena-Raluca
Brooks, Brian P.
Huryn, Laryssa
Titus, Steven A.
Adams, David R.
Chen, Dong
Gahl, William A.
Gochuico, Bernadette R.
Malicdan, May Christine V.
Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5
title Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5
title_full Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5
title_fullStr Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5
title_full_unstemmed Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5
title_short Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5
title_sort cellular and molecular defects in a patient with hermansky-pudlak syndrome type 5
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351877/
https://www.ncbi.nlm.nih.gov/pubmed/28296950
http://dx.doi.org/10.1371/journal.pone.0173682
work_keys_str_mv AT stephenjoshi cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5
AT yokoyamatadafumi cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5
AT tolmannathanialj cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5
AT obrienkevinj cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5
AT nicolielenaraluca cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5
AT brooksbrianp cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5
AT hurynlaryssa cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5
AT titusstevena cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5
AT adamsdavidr cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5
AT chendong cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5
AT gahlwilliama cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5
AT gochuicobernadetter cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5
AT malicdanmaychristinev cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5